Article

Promising Cancer Trials Highlight Specialty Pharmacy Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/patient-support" target="_blank">View the story "Promising Cancer Trials Highlight Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy Benefit Manager Transparency | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Benefit Manager Regulation | Image Credit: Tyler Olson - stock.adobe.com
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication
Related Content
Oral Semaglutide, GLP-1, Diabetes, MACE | Image Credit: Chinnapong - stock.adobe.com
October 29th 2024

Oral Semaglutide Reduces Risk of MACE for Patients With Type 2 Diabetes

Ashley Gallagher, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Associate Editor
Chronic kidney disease, doctor holding model for treatment urinary system, urology, Estimated glomerular filtration rate eGFR - Image credit: manassanant | stock.adobe.com
October 25th 2024

Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy

Kennedy Ferruggia, Assistant Editor
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations
January 25th 2024

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

Gene therapy -- Image credit: RFBSIP | stock.adobe.com
Published: October 25th 2024 | Updated: October 25th 2024

FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a

Gillian McGovern, Assistant Editor
Aerobic exercise -- Image credit: Kalim | stock.adobe.com
October 24th 2024

Women Beginning Chemotherapy for Breast Cancer Self-Report Improved Cognitive Function When Participating in Aerobic Exercise

Gillian McGovern, Assistant Editor